Funder: Ionis Pharmaceuticals
Due Dates: Rolling (submit at least 60 days before project start)
Funding Amounts: No fixed limit; award size and duration depend on project scope, budget, and Ionis resource availability.
Summary: Supports independent, investigator-initiated research in cardiovascular/metabolic diseases (e.g., severe hypertriglyceridemia) and pulmonary/allergy (e.g., hereditary angioedema) aligned with Ionis’ priorities.
Key Information: Proposals are unsolicited and investigator-driven; submission does not guarantee funding.